|
1
|
Quinn KL, Fralick M, Zipursky JS, Stall NM. Further developments in the literature on RAAS inhibitors and COVID-19. CMAJ 2020; 192:E727. [PMID: 32601253 PMCID: PMC7828885 DOI: 10.1503/cmaj.76076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
Affiliation(s)
- Kieran L Quinn
- General internist and palliative care physician, Department of Medicine, University of Toronto; Division of General Internal Medicine and Geriatrics, Sinai Health System; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ont
| | - Michael Fralick
- Clinician scientist, Department of Medicine, University of Toronto; Division of General Internal Medicine and Geriatrics, Sinai Health System, Toronto, Ont
| | - Jonathan S Zipursky
- Resident in internal medicine, Department of Medicine, University of Toronto; Institute of Health Policy, Management and Evaluation, University of Toronto; Division of Clinical Pharmacology and Toxicology, Sunnybrook Health Sciences Centre, Toronto, Ont
| | - Nathan M Stall
- PhD student, Department of Medicine, University of Toronto; Division of General Internal Medicine and Geriatrics, Sinai Health System; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ont
| |
Collapse
|